Institut für Organische und Biomolekulare Chemie der Georg-August-Universität, Tammannstrasse 2, 37077 Göttingen, Germany.
Chemistry. 2010 Dec 10;16(46):13862-75. doi: 10.1002/chem.201001550.
Thirty-three different N,N-dialkyl- and N-alkyl-N-phosphorylalkyl-substituted carboxamides 9-17 were treated with unsubstituted as well as with 2-alkyl-, 2,2-dialkyl-, and 3-alkenyl-substituted ethylmagnesium bromides 6 in the presence of stoichiometric amounts of titanium tetraisopropoxide or methyltitanium triisopropoxide to furnish substituted cyclopropylamines 20-25 in 20-98% yield, depending on the substituents with no (1:1) to excellent (>25:1) diastereoselectivities. Generally higher yields (up to 98%) of the cyclopropylamines 20-28 without loss of the diastereoselectivity were obtained with methyltitanium triisopropoxide as the titanium mediator. Under these conditions, even dioxolane-protected ketones and halogen-substituted and chiral as well as achiral alkyloxyalkyl-substituted carboxamides could be converted to the correspondingly substituted cyclopropylamines with unsubstituted as well as phenyl- and a variety of alkyl-substituted ethylmagnesium bromides in addition to numerous heteroatom-containing (e.g., halogen-, trityloxy-, tetrahydropyranyloxy-substituted) Grignard reagents (62 examples altogether). The transformation of N,N-diformylalkylamines 54 with ethylmagnesium bromide in the presence of methyltitanium triisopropoxide to N,N-dicyclopropyl-N-alkylamines 55 can be brought about in up to 82% yield (6 examples). An asymmetric variant of the titanium-mediated cyclopropanation of N,N-dialkylcarboxamides has been developed by applying chiral titanium mediators generated from stoichiometric amounts of titanium tetraisopropoxide and chiral diamino or diol ligands, respectively. The most efficient chiral mediators turned out to be titanium bistaddolates that provided the corresponding cyclopropylamines with enantiomeric excesses (ee) of up to 84%. Evaluation of several silyl-based additives revealed that the reaction can also efficiently be carried out with substoichiometric amounts (down to 25 mol%) of the titanium reagent, as long as 2-aryl- or 2-ethenyl-substituted ethylmagnesium halides are used and a concomitant slight decrease in yields is accepted. The newly developed methodology was successfully applied for the preparation of analogues with cyclopropylamine moieties of known drugs and natural products such as the nicotine metabolite (S)-Cotinine as well as the insecticides Dinotefuran and Imidacloprid.
33 种不同的 N,N-二烷基-和 N-烷基-N-膦酰基烷基取代的羧酰胺 9-17 在化学计量的钛四异丙醇酯或甲基钛三异丙醇酯存在下与未取代的以及 2-烷基、2,2-二烷基和 3-烯基取代的乙基溴镁 6 反应,得到取代的环丙胺 20-25,收率为 20-98%,具体取决于取代基,非对映选择性为无(1:1)至极好(>25:1)。一般来说,使用甲基钛三异丙醇酯作为钛介体,可以获得更高的环丙胺 20-28 产率(高达 98%),而不会损失非对映选择性。在这些条件下,即使是二氧杂环戊烷保护的酮和卤素取代以及手性和非手性烷氧基烷基取代的羧酰胺也可以与未取代的以及苯基和各种烷基取代的乙基溴镁以及许多含杂原子的(例如,卤素、三苯甲氧基、四氢吡喃氧基取代)格氏试剂(总共 62 个例子)反应得到相应取代的环丙胺。在甲基钛三异丙醇酯存在下,用乙基溴镁处理 N,N-二甲酰基烷基胺 54 可以得到 N,N-二环丙基-N-烷基胺 55,产率高达 82%(6 个例子)。通过应用分别由化学计量的钛四异丙醇酯和手性二氨基或二醇配体生成的手性钛介体,开发了 N,N-二烷基羧酰胺的钛介导环丙烷化的不对称变体。最有效的手性介体是钛双螺二唑酯,它提供的相应环丙胺的对映过量(ee)高达 84%。评估了几种硅基添加剂,发现只要使用 2-芳基或 2-乙烯基取代的乙基溴镁卤化物,并且可以接受产率略有降低,该反应也可以用亚化学计量(低至 25mol%)的钛试剂有效地进行。新开发的方法成功地应用于制备具有已知药物和天然产物(如尼古丁代谢物(S)-可替宁以及杀虫剂 Dinotefuran 和 Imidacloprid)中环丙胺部分的类似物。